A Win For Mind Medicine (MindMed) Inc.
Tue, Jan 25, 2022 at 05:30 PM
Mind Medicine (MindMed) Inc. (MNMD:NASDAQ) rocketted at $1.17, a gain of 25.5%. On Mon, Jan 24, 2022, MNMD:NASDAQ hit a New 2-Week Low of $0.93. The stock got featured on our News Catalysts scanner on Tue, Jan 25, 2022 at 08:05 AM in the 'BIOTECH' category. From Tue, Jan 11, 2022, the stock recorded 12.50% Up Days and 33.33% Green Days
About Mind Medicine (MindMed) Inc. (MNMD:NASDAQ)
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.
Top 10 Gainers:
- Capitalworks Emerging Markets Acquisition Corp (CMCA:NASDAQ), 100%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 46.23%
- Aptorum Group Limited (APM:NASDAQ), 38.89%
- Exela Technologies, Inc. (XELA:NASDAQ), 32.95%
- Vistas Media Acquisition Company Inc. (VMAC:NASDAQ), 27.29%
- Aditxt Inc. (ADTX:NASDAQ), 25.66%
- Mind Medicine (MindMed) Inc. (MNMD:NASDAQ), 25.48%
- SmileDirectClub, Inc. (SDC:NASDAQ), 24.62%
- ClearOne, Inc. (CLRO:NASDAQ), 23.46%
- Bally's Corporation (BALY:NYSE), 22.65%